Novavax (NVAX) Q1 earnings report 2023


A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands.

Patrick Van Katwijk | Getty Images

Share prices of Novavax jumped about 30% on Tuesday after the biotech company unveiled promising new vaccine data and a broad cost-cutting push that includes major layoffs. 

The announcements are a sign of hope for investors after last quarter, when the company raised doubts about its ability to stay in business and decided not to provide full-year guidance. Novavax’s share prices are now up about 6% so far this year, giving it a market value of nearly $950 million.


Source cnbc.com

0 0 votes
Article Rating

Germany’s BaFin warns of nervous time for banks, stress in property markets

Previous article

Fed’s John Williams says rates could be increased if inflation doesn’t come down

Next article

You may also like

Notify of
Inline Feedbacks
View all comments

More in Earnings